CDH1 and lung carcinoma: The experiments indicated that there is a dynamic and inverse correlation between downregulation in the levels of CDH1 (encoding the epithelial cell marker E-cadherin) and the observed increase in the IL2RA (encoding the Treg marker CD25) in stage IV lung cancer patients resistant to chemotherapy (35).